Correlation Between Rezolute and Kymera Therapeutics
Can any of the company-specific risk be diversified away by investing in both Rezolute and Kymera Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Rezolute and Kymera Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Rezolute and Kymera Therapeutics, you can compare the effects of market volatilities on Rezolute and Kymera Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Rezolute with a short position of Kymera Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Rezolute and Kymera Therapeutics.
Diversification Opportunities for Rezolute and Kymera Therapeutics
0.33 | Correlation Coefficient |
Weak diversification
The 3 months correlation between Rezolute and Kymera is 0.33. Overlapping area represents the amount of risk that can be diversified away by holding Rezolute and Kymera Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Kymera Therapeutics and Rezolute is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Rezolute are associated (or correlated) with Kymera Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Kymera Therapeutics has no effect on the direction of Rezolute i.e., Rezolute and Kymera Therapeutics go up and down completely randomly.
Pair Corralation between Rezolute and Kymera Therapeutics
Given the investment horizon of 90 days Rezolute is expected to generate 1.53 times less return on investment than Kymera Therapeutics. In addition to that, Rezolute is 1.25 times more volatile than Kymera Therapeutics. It trades about 0.05 of its total potential returns per unit of risk. Kymera Therapeutics is currently generating about 0.09 per unit of volatility. If you would invest 3,216 in Kymera Therapeutics on August 28, 2024 and sell it today you would earn a total of 1,486 from holding Kymera Therapeutics or generate 46.21% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Rezolute vs. Kymera Therapeutics
Performance |
| Timeline |
| Rezolute |
| Kymera Therapeutics |
Rezolute and Kymera Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Rezolute and Kymera Therapeutics
The main advantage of trading using opposite Rezolute and Kymera Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Rezolute position performs unexpectedly, Kymera Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Kymera Therapeutics will offset losses from the drop in Kymera Therapeutics' long position.The idea behind Rezolute and Kymera Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.| Kymera Therapeutics vs. Foghorn Therapeutics | Kymera Therapeutics vs. Shattuck Labs | Kymera Therapeutics vs. Monte Rosa Therapeutics | Kymera Therapeutics vs. Nurix Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.
Other Complementary Tools
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated |